Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ASBPthis companyAspire Biopharma Holdings, Inc.	$8.03	-9.67×	-37.14×	38,181.4×	-20.93×	-107.4%	-1.9%	-312016.9%	-394725.1%	383.9%	395.3%	-2.1%	-0.22×	-0.03×	-2.27×	0.17×	0.0%	5	-3.49	2	C
ANNAAleAnna, Inc.	$2.00	65.16×	3.3×	4.67×	0.03×	1520.4%	63.0%	11.6%	7.2%	5.1%	2.4%	2.7%	0.05×	-0.01×	0×	1.93×	0.0%	5	-0.02	4	A-
Peer median	—	65.16×	3.3×	4.67×	0.03×	1520.4%	63.0%	11.6%	7.2%	5.1%	2.4%	2.7%	0.05×	-0.01×	0×	1.93×	0.0%	5	-0.02	4	—